prikaz prve stranice dokumenta ANEMIJA U NEDONOŠČADI :ZNAČENJE HUMANOGA REKOMBINANTNOG ERITROPOETINA
  Download
PDF 72.52 KB
Professional paper - Review paper
ANEMIJA U NEDONOŠČADI :ZNAČENJE HUMANOGA REKOMBINANTNOG ERITROPOETINA
Medicina, 39 (2003), 1; 42-45. urn:nbn:hr:184:764571
Zaputović, Sanja; Krajina, Robert; Samardžija, Radojka; Prpić, Igor

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Zaputović, S., Krajina, R., Samardžija, R. & Prpić, I. (2003). ANEMIJA U NEDONOŠČADI :ZNAČENJE HUMANOGA REKOMBINANTNOG ERITROPOETINA. Medicina, 39. (1), 42-45. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:764571

Zaputović, Sanja, et al. "ANEMIJA U NEDONOŠČADI :ZNAČENJE HUMANOGA REKOMBINANTNOG ERITROPOETINA." Medicina, vol. 39, no. 1, 2003, pp. 42-45. https://urn.nsk.hr/urn:nbn:hr:184:764571

Zaputović, Sanja, Robert Krajina, Radojka Samardžija and Igor Prpić. "ANEMIJA U NEDONOŠČADI :ZNAČENJE HUMANOGA REKOMBINANTNOG ERITROPOETINA." Medicina 39, no. 1 (2003): 42-45. https://urn.nsk.hr/urn:nbn:hr:184:764571

Zaputović, S., et al. (2003) 'ANEMIJA U NEDONOŠČADI :ZNAČENJE HUMANOGA REKOMBINANTNOG ERITROPOETINA', Medicina, 39(1), pp. 42-45. Available at: https://urn.nsk.hr/urn:nbn:hr:184:764571 (Accessed 04 May 2024)

Zaputović S, Krajina R, Samardžija R, Prpić I. ANEMIJA U NEDONOŠČADI :ZNAČENJE HUMANOGA REKOMBINANTNOG ERITROPOETINA. Medicina [Internet]. 2003 [cited 2024 May 04];39(1):42-45. Available at: https://urn.nsk.hr/urn:nbn:hr:184:764571

S. Zaputović, R. Krajina, R. Samardžija and I. Prpić, "ANEMIJA U NEDONOŠČADI :ZNAČENJE HUMANOGA REKOMBINANTNOG ERITROPOETINA", Medicina, vol. 39, no. 1, pp. 42-45, 2003. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:764571. [Accessed: 04 May 2024]

Metadata
Title (croatian)ANEMIJA U NEDONOŠČADI :ZNAČENJE HUMANOGA REKOMBINANTNOG ERITROPOETINA
Title (english)ANEMIA IN PREMATURITY · THE ROLE OF HUMAN RECOMBINANT ERYTHOROPOIETIN
AuthorSanja Zaputović
AuthorRobert Krajina
AuthorRadojka Samardžija
AuthorIgor Prpić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Pediatrics)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Gynecology and Obstetrics
Abstract (croatian)
Anemija u nedonoščadi je patološko stanje koje u pravilu pogaða novoroðenčad vrlo niske rodne mase. Uzrok anemije je nedovoljno stvaranje eritropoetina. Osnova liječenja su transfuzije koje bolesnika izlaæu mnogim nepoželjnim učincima. Pojava sintetskih rekombinantnih humanih eritropoetina (rHuEPO) pružila je mogućnost poticanja vlastite eritropoeze i time smanjila potrebu za transfuzijama. Primjena rekombinantnoga humanog eritropoetina ne dovodi do supresije vlastite proizvodnje eritropoetina u nedonoščadi. Nuspojave koje se javljaju tijekom ili nakon liječenja anemije, rijetko su zamijećene. Primjena rHuEPO u nedonoščadi ne utječe na rast. U liječenju anemije zbog nedonošenosti, uz rHuEPO potrebno je osigurati primjeren unos željeza, vitamina i bjelančevina. Racionalna primjena eritropoetina u prevenciji i liječenju anemije zbog nedonošenosti, svakako znači napredak u cjelokupnoj skrbi za prijevremeno roðenu djecu.
Abstract (english)
Anemia in prematures is a pathological state usually present in neonates with low birth weight. The cause of anemia is insufficient erythropoietin secretion. The principal treatment previously were blood transfusions which exposed the patients to many adverse effects. Discovery of synthetic recombinant human erythropoietins (rHuEPO) has given the opportunity to induce patient's erythropoiesis and reduce the need for blood transfusions. The use of rHuEPO in such condition doesn't suppress patient's own erythropoiesis, with low incidence of adverse events during and after the treatment. At the same time, rHuEPO doesn't influence patient's growth. Treatment of anemia in prematurity, beside the use of rHuEPO, also must include adequate iron, vitamins and proteins intake. The introduction and rational use of rHuEPO in the prevention and treatment of anemia in prematures certainly represents the significant progress in total medical care for such premature born children.
Keywords (croatian)
Keywords (english)
Languagecroatian
Publication typeProfessional paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleMedicina
Numberingvol. 39, no. 1, pp. 42-45
p-ISSN0025-7729
URN:NBNurn:nbn:hr:184:764571
Publication2003
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2017-06-06 13:16:02